PubMed:16371368 / 1839-2032
Annnotations
sonoma2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T-69 | 36-41 | GENE | denotes | SHP-2 |
T-70 | 66-80 | VAR | denotes | C459S mutation |
T-71 | 108-116 | POSREG | denotes | increase |
T-72 | 121-132 | INTERACTION | denotes | interaction |
T-73 | 138-142 | GENE | denotes | Gab2 |
T-74 | 150-157 | POSREG | denotes | enhance |
T-75 | 180-192 | PATHWAY | denotes | PI3K pathway |
R-85 | T-69 | T-70 | ThemeOf | SHP-2,C459S mutation |
R-86 | T-70 | T-71 | CauseOf | C459S mutation,increase |
R-87 | T-70 | T-74 | CauseOf | C459S mutation,enhance |
R-88 | T-72 | T-71 | ThemeOf | interaction,increase |
R-89 | T-73 | T-72 | ThemeOf | Gab2,interaction |
R-90 | T-75 | T-74 | ThemeOf | PI3K pathway,enhance |
sonoma
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T-72 | 27-35 | NEGREG | denotes | inactive |
T-73 | 36-41 | GENE | denotes | SHP-2 |
T-74 | 42-46 | VAR | denotes | E76K |
T-75 | 66-80 | VAR | denotes | C459S mutation |
T-76 | 108-116 | POSREG | denotes | increase |
T-77 | 121-132 | INTERACTION | denotes | interaction |
T-78 | 138-142 | GENE | denotes | Gab2 |
T-79 | 150-157 | POSREG | denotes | enhance |
T-80 | 180-192 | PATHWAY | denotes | PI3K pathway |
R-132 | T-72 | T-73 | ThemeOf | inactive,SHP-2 |
R-133 | T-72 | T-74 | CauseOf | inactive,E76K |
R-134 | T-72 | T-75 | CauseOf | inactive,C459S mutation |
R-135 | T-72 | T-76 | CauseOf | inactive,increase |
R-136 | T-72 | T-79 | CauseOf | inactive,enhance |
R-137 | T-73 | T-74 | ThemeOf | SHP-2,E76K |
R-138 | T-73 | T-75 | ThemeOf | SHP-2,C459S mutation |
R-139 | T-73 | T-77 | ThemeOf | SHP-2,interaction |
R-140 | T-74 | T-76 | CauseOf | E76K,increase |
R-141 | T-74 | T-79 | CauseOf | E76K,enhance |
R-142 | T-75 | T-76 | CauseOf | C459S mutation,increase |
R-143 | T-75 | T-79 | CauseOf | C459S mutation,enhance |
R-144 | T-76 | T-77 | ThemeOf | increase,interaction |
R-145 | T-76 | T-78 | ThemeOf | increase,Gab2 |
R-146 | T-76 | T-79 | CauseOf | increase,enhance |
R-147 | T-77 | T-78 | ThemeOf | interaction,Gab2 |
R-148 | T-77 | T-79 | ThemeOf | interaction,enhance |
R-149 | T-77 | T-80 | ThemeOf | interaction,PI3K pathway |
R-150 | T-79 | T-80 | ThemeOf | enhance,PI3K pathway |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 0-193 | Sentence | denotes | Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to enhance the activation of the PI3K pathway. |
kaiyin_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T27 | 13-80 | Var | denotes | catalytically inactive SHP-2 E76K with an additional C459S mutation |
T28 | 108-116 | PosReg | denotes | increase |
T29 | 121-132 | Interaction | denotes | interaction |
T30 | 138-142 | Protein | denotes | Gab2 |
T31 | 150-157 | PosReg | denotes | enhance |
T32 | 162-192 | Pathway | denotes | activation of the PI3K pathway |
R18 | T27 | T28 | CauseOf | catalytically inactive SHP-2 E76K with an additional C459S mutation,increase |
R19 | T29 | T28 | ThemeOf | interaction,increase |
R20 | T30 | T29 | ThemeOf | Gab2,interaction |
R21 | T27 | T31 | CauseOf | catalytically inactive SHP-2 E76K with an additional C459S mutation,enhance |
R22 | T32 | T31 | ThemeOf | activation of the PI3K pathway,enhance |
name_no
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T27 | 13-80 | Var | denotes | catalytically inactive SHP-2 E76K with an additional C459S mutation |
T28 | 108-116 | PosReg | denotes | increase |
T29 | 121-132 | Interaction | denotes | interaction |
T30 | 138-142 | Protein | denotes | Gab2 |
T31 | 150-157 | PosReg | denotes | enhance |
T32 | 162-192 | Pathway | denotes | activation of the PI3K pathway |
R18 | T27 | T28 | CauseOf | catalytically inactive SHP-2 E76K with an additional C459S mutation,increase |
R19 | T29 | T28 | ThemeOf | interaction,increase |
R20 | T30 | T29 | ThemeOf | Gab2,interaction |
R21 | T27 | T31 | CauseOf | catalytically inactive SHP-2 E76K with an additional C459S mutation,enhance |
R22 | T32 | T31 | ThemeOf | activation of the PI3K pathway,enhance |